Ongoing advances in the accuracy and affordability of continuous glucose monitoring technologies have led to a growing emphasis on time-in-range as a primary metric in pediatric diabetes. A panel of experts, including Daniel J. DeSalvo, MD, will review the growing evidence supporting time-in-range and discuss recommendations for incorporating the metric into clinical practice during the Joint ADA/ISPAD Symposium, which begins at 1:45 p.m. CT.
Beginning soon: Joint symposium to examine role of time-in-range in pediatric diabetes
